Ambu AS (CHIX:AMBUBC) Other Long-Term Liabilities: kr7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AMBUBC Ambu AS CHIX:AMBUBC
91 GF Score
Price kr66.90
GF Value kr115.27
View Full Analysis

What is Ambu AS Other Long-Term Liabilities?

Ambu AS CHIX:AMBUBC 91 Other Long-Term Liabilities is kr7 Mil as of Mar. 2026. GuruFocus rates CHIX:AMBUBC with a GF Score™ of 91/100 and a GF Value™ of kr115.27.

Ambu AS's other long-term liabilities for the quarter that ended in Mar. 2026 was kr7 Mil.

Ambu AS's quarterly other long-term liabilities declined from Sep. 2025 (kr14 Mil) to Dec. 2025 (kr7 Mil) but then stayed the same from Dec. 2025 (kr7 Mil) to Mar. 2026 (kr7 Mil).

Ambu AS's annual other long-term liabilities increased from Sep. 2023 (kr12 Mil) to Sep. 2024 (kr18 Mil) but then declined from Sep. 2024 (kr18 Mil) to Sep. 2025 (kr14 Mil).

Ambu AS Other Long-Term Liabilities Related Terms

Ambu AS Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Ambu AS's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Other Long-Term Liabilities Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.00 27.00 12.00 18.00 14.00

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.00 18.00 14.00 7.00 7.00
CHIX:AMBUBC
91GF Score
Ambu AS CHIX:AMBUBC
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of kr7 Mil mean?
Ambu AS (CHIX:AMBUBC) has a Other Long-Term Liabilities of kr7 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambu AS and its competitors.
Is Ambu AS's Other Long-Term Liabilities too high?
Ambu AS's current Other Long-Term Liabilities is kr7 Mil. Overall, Ambu AS has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Other Long-Term Liabilities compare to ABT and SYK?
Ambu AS's Other Long-Term Liabilities of kr7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambu AS and its competitors. Ambu AS's current Other Long-Term Liabilities is kr7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Ambu AS (CHIX:AMBUBC) has a current Other Long-Term Liabilities of kr7 Mil. The stock's GF Value™ is kr115.27, compared to a current price of kr66.90 — trading 42% below its estimated fair value. The current Other Long-Term Liabilities is kr7 Mil. Ambu AS's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Ambu AS (CHIX:AMBUBC), the current Other Long-Term Liabilities is kr7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (CHIX:AMBUBC) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of kr66.90 is trading 42% below its estimated GF Value™ of kr115.27.

Key valuation signals for CHIX:AMBUBC:

  • Other Long-Term Liabilities: kr7 Mil
  • GF Value™: kr115.27 vs. price of kr66.90 (42% below fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the CHIX:AMBUBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
91GF Score

Get the complete analysis for CHIX:AMBUBC

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr66.90
Price
kr115.27
GF Value